Abstract

The present study aims to investigate microRNAs (miRNAs) and messenger RNAs (mRNAs) associated with breast cancer, and to have a better understanding of the mechanism of miRNAs in breast cancer using bioinformatics tools. Microarray analysis was performed to predict differentially expressed miRNAs related to breast cancer, followed by prediction and verification of target genes. Human breast cancer cells were transfected and divided into Blank group, NC group, miR-21-5p mimic group, miR-21-5p inhibitor group and siRNA-MAPK10 group. RT-qPCR and Western blot analysis were used to detect mRNA and protein expressions of MAPK10 in tissues and transfected cells, MTT assay, scratch test and Transwell assay for detection of the proliferation, migration and invasion, and Annexin-V-R-PE assay for apoptosis of different cell lines. Highly expressed miR-21-5p and lowly expressed MAPK10 were selected for subsequent experiments, according to the microarray analysis. RT-qPCR showed that the expression of MAPK10 in breast cancer tissues was significantly lower than that in adjacent tissues, while it was reciprocal in expression of miR-21. miR-21-5p negatively regulated MAPK10. The expression of MAPK10 reduced in response to miR-21-5p mimic treatment. Compared with the Blank and NC groups, the proliferation, migration, invasion and metastasis of breast cancer cells decreased, and the apoptosis of breast cancer cells increased in the miR-21-5p inhibitor group and siRNA-MAPK10 group, while it was reciprocal in the miR-21-5p mimic group. MiR-21 promotes the proliferation, migration and invasion and inhibits the apoptosis of breast cancer cells by inhibiting MAPK10.

Highlights

Read more

Summary

Introduction

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.